Laber DA - Search Results

1

Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers.

Harandi A, Zaidi AS, Stocker AM, Laber DA. Harandi A, et al. Among authors: laber da. J Oncol. 2009;2009:567486. doi: 10.1155/2009/567486. Epub 2009 May 6. J Oncol. 2009. PMID: 19424511 Free PMC article.

2

Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary.

Jaglal MV, Laber DA, Arnold FW, Miller DM, Chesney JA, Kloecker GH. Jaglal MV, et al. Among authors: laber da. Am J Clin Oncol. 2009 Aug;32(4):429-31. doi: 10.1097/COC.0b013e31819142c7. Am J Clin Oncol. 2009. PMID: 19451801

3

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma.

Laber DA, Okeke RI, Arce-Lara C, Taft BS, Schonard CL, McMasters KM, Kloecker GH, Miller DM. Laber DA, et al. J Cancer Res Clin Oncol. 2006 Sep;132(9):611-6. doi: 10.1007/s00432-006-0114-8. Epub 2006 Jun 2. J Cancer Res Clin Oncol. 2006. PMID: 16741726 Free PMC article. Clinical Trial.

4

A phase II study of higher dose docetaxel in androgen-independent prostate cancer.

Laber DA, Glisson SD, Hargis JB, Kosfeld RE, Goldsmith G, Cervera A, La Rocca RV. Laber DA, et al. Am J Clin Oncol. 2006 Aug;29(4):389-94. doi: 10.1097/01.coc.0000221357.12412.b7. Am J Clin Oncol. 2006. PMID: 16891868 Clinical Trial.

5

Risk factors, classification, and staging of renal cell cancer.

Laber DA. Laber DA. Med Oncol. 2006;23(4):443-54. doi: 10.1385/MO:23:4:443. Med Oncol. 2006. PMID: 17303902 Review.

6

Indolent course of thymic carcinoid.

Rabinowits G, Shuster TD, Pazianos AG, Laber DA. Rabinowits G, et al. Among authors: laber da. J Clin Oncol. 2007 Mar 20;25(9):1138-9. doi: 10.1200/JCO.2006.09.8855. J Clin Oncol. 2007. PMID: 17369578 No abstract available.

7

Diagnosing and managing suspected malignant pleural effusions.

Moffett PU, Moffett BK, Laber DA. Moffett PU, et al. Among authors: laber da. J Support Oncol. 2009 Jul-Aug;7(4):143-6. J Support Oncol. 2009. PMID: 19731581 Review. No abstract available.

8

Spontaneous complete regression of hepatocellular carcinoma.

Storey RE, Huerta AL, Khan A, Laber DA. Storey RE, et al. Among authors: laber da. Med Oncol. 2011 Dec;28(4):948-50. doi: 10.1007/s12032-010-9562-8. Epub 2010 May 14. Med Oncol. 2011. PMID: 20467917

9

Digitalis, a targeted therapy for cancer?

Khan MI, Chesney JA, Laber DA, Miller DM. Khan MI, et al. Among authors: laber da. Am J Med Sci. 2009 May;337(5):355-9. doi: 10.1097/MAJ.0b013e3181942f57. Am J Med Sci. 2009. PMID: 19440057 Review.

10

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. Bates PJ, et al. Among authors: laber da. Exp Mol Pathol. 2009 Jun;86(3):151-64. doi: 10.1016/j.yexmp.2009.01.004. Epub 2009 Jan 20. Exp Mol Pathol. 2009. PMID: 19454272 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters